Patient-led non-profit with a goal of advancing standards of care for primary aldosteronism. Committed to fostering actionable research/inclusive collaboration.
Thrilled to share my memoir Misdiagnosed for Miles! It’s my journey as a competitive runner overcoming health challenges, including #PrimaryAldosteronism. Huge thanks to @WeArePAOrg for supporting this mission to raise awareness. Pre-order here: https://t.co/UdF2BjSzH6 #Running
Thrilled to share my memoir Misdiagnosed for Miles! It’s my journey as a competitive runner overcoming health challenges, including #PrimaryAldosteronism. Huge thanks to @WeArePAOrg for supporting this mission to raise awareness. Pre-order here: https://t.co/UdF2BjSzH6 #Running
A big thank you to the signers of our Open Letter! Let’s add more signatures and forward the letter wherever we can. Millions of patients with primary aldosteronism need diagnosis and treatment: https://t.co/0EJ6V1Bf56
A big thank you to the signers of our Open Letter! Let’s add more signatures and forward the letter wherever we can. Millions of patients worldwide need diagnosis and treatment: https://t.co/0EJ6V1Bf56
We’ve earned a Gold Seal from @CandidDotOrg, the world's largest source of nonprofit information. This award reflects our commitment to accountability and impact. On behalf of patients with #primaryaldosteronism, thank you for supporting us! https://t.co/MqgbC00zgD
@GalavitzRowena The PA Foundation does not state that MECFS and MCAS are comorbidities of PA, rather that based on lived experiences, they are found in some patients with PA and that research has not yet formally established the actual burden of disease of PA.
We have been awarded “2024 top-rated” by #greatnonprofits. Thank you to those who support us, and make advancing standards of care a reality for patients with #primaryaldosteronism. Read our reviews and add your own: https://t.co/EfD5KvOrvc
We’re thrilled to announce an initiative aiming to advance standards of care for primary #aldosteronism, a highly prevalent adrenal disease and common cause of #hypertension, in collaboration with over 30 founding members. Read more: https://t.co/j8mHE8QRwH
On #ClinicalTrialsDay, thank you to the patients, doctors, researchers & coordinators working to help those suffering with #PA. The work to advance the development of new drugs & understanding this overlooked disease will change millions of lives. #CTD2022 https://t.co/cm4B8stOfl
Today is #WorldHypertensionDay. Primary #aldosteronism, is a common treatable & potentially curable form of #hypertension. Once considered rare, #PA is gaining attention in the medical community. If you have uncontrolled #HTN you may have PA. See here: https://t.co/cm4B8stOfl
Excess #aldosterone causes #heart and #kidneydisease, and systemic inflammation. Diagnostic and treatment are important! Learn more here: https://t.co/RxzGNQMirB
Primary aldosteronism is the most common specifically treatable and potentially curable causes of hypertension, but can be missed because it has traditionally been considered rare.
How can clinicians diagnose and manage this condition?
https://t.co/WKUiQk4m5z
We are so encouraged to see #primaryaldosteronism being discussed more broadly. Thank you to this fantastic team for bringing this important diagnosis, that affects so many patients, out of the shadows.
"Primary aldosteronism is missed because it has traditionally been considered rare and screening is not generally recommended in patients without hypokalaemia or resistant hypertension."
How can clinicians diagnose and manage this condition?
https://t.co/WKUiQk4m5z
Primary #aldosteronism causes chronic kidney disease. During #NationalKidneyMonth, get tested for PA. It may affect up to 50% of #hypertensives. Its treatment prevents #kidney damage. Find out more here: https://t.co/ljv904AO5p